A detailed history of Highlander Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Highlander Capital Management, LLC holds 153 shares of ABBV stock, worth $27,235. This represents 0.01% of its overall portfolio holdings.

Number of Shares
153
Previous 227 32.6%
Holding current value
$27,235
Previous $35,000 22.86%
% of portfolio
0.01%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

SELL
$159.82 - $182.1 $11,826 - $13,475
-74 Reduced 32.6%
153 $27,000
Q4 2022

Feb 15, 2023

SELL
$138.31 - $165.87 $6,915 - $8,293
-50 Reduced 18.05%
227 $36,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $113,536 - $144,342
-825 Reduced 74.86%
277 $42,000
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $85,787 - $106,437
-650 Reduced 37.1%
1,102 $179,000
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $31,920 - $36,234
-300 Reduced 14.62%
1,752 $189,000
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $158,565 - $174,561
1,550 Added 308.76%
2,052 $222,000
Q3 2020

Nov 17, 2020

BUY
$85.91 - $100.83 $25,773 - $30,249
300 Added 148.51%
502 $44,000
Q2 2020

Aug 17, 2020

BUY
$73.37 - $98.18 $14,820 - $19,832
202 New
202 $20,000
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $32,850 - $41,990
-500 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $38,570 - $45,395
-500 Reduced 50.0%
500 $40,000
Q1 2018

May 16, 2018

BUY
$92.01 - $123.21 $46,005 - $61,605
500 Added 100.0%
1,000 $97,000
Q3 2017

Nov 15, 2017

BUY
$69.85 - $89.22 $34,925 - $44,610
500
500 $44,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Highlander Capital Management, LLC Portfolio

Follow Highlander Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highlander Capital Management, LLC with notifications on news.